Efficacy of ranitidine bismuth citrate (RBC) dual and triple therapies for the eradication of Helicobacter pylori
Duggan, A.; Williamson, R.
Gut 42(4): 596-597
1998
ISSN/ISBN: 0017-5749 PMID: 9616332 Document Number: 495438
Document emailed within 1 workday
Related Documents
Thong-Ngam, D.; Tangkijvanich, P.; Treeprasertsuk, S.; Wisedopas, N.; Kullavanijaya, P. 2002: Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori Journal of the Medical Association of Thailand 85(10): 1054-1059Marini, R.P.; Fox, J.G.; Taylor, N.S.; Yan, L.; McColm, A.A.; Williamson, R. 1999: Ranitidine bismuth citrate and clarithromycin, alone or in combination, for eradication of Helicobacter mustelae infection in ferrets American Journal of Veterinary Research 60(10): 1280-1286
Laine, L.; Stein, C.; Neil, G. 1995: Limited efficacy of omeprazole-based dual and triple therapy for Helicobacter pylori: a randomized trial employing "optimal" dosing American Journal of Gastroenterology 90(9): 1407-1410
Koizumi, W.; Tanabe, S.; Imaizumi, H.; Kida, M.; Ohida, M.; Koshida, Y.; Mitomi, H.; Hosaka, Y.; Nagaba, S.; Sasaki, T.; Higuchi, K.; Saigenji, K. 2003: Inhibition of peptic ulcer relapse by ranitidine and ecabet independently of eradication of Helicobacter pylori: a prospective, controlled study versus ranitidine Hepato-Gastroenterology 50(50): 577-581
Frotz, H.; Ahrends, H.; Hebbeln, H.; Klass, D.; Miederer, S.E.; Mittelstaedt, A.; Rolfs, H.C.; von Geldern, R. 1995: Ranitidine and clarithromycin for eradication of Helicobacter pylori in patients with duodenal ulcer Arzneimittel-Forschung 45(2): 184-186
Karita, M.; Morshed, M.G.; Ouchi, K.; Okita, K. 1994: Bismuth-free triple therapy for eradicating Helicobacter pylori and reducing the gastric ulcer recurrence rate American Journal of Gastroenterology 89(7): 1032-1035
Ren, Q.; Ma, B.; Yang, K.; Yan, X. 2010: Lafutidine-based triple therapy for Helicobacter pylori eradication Hepato-Gastroenterology 57: 102-103
Borody, T.J. 1998: Helicobacter pylori eradication failure--'salvage' therapies needed Italian Journal of Gastroenterology and Hepatology 30(4): 375-377
Labenz, J.; Gyenes, E.; Rühl, G.H.; Börsch, G. 1993: Oral triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease Medizinische Klinik 88(5): 297-299
Aminian, K.; Farsad, F.; Ghanbari, A.; Fakhreih, S.; Hasheminasab, S.M. 2010: A randomized trial comparing four Helicobacter pylori eradication regimens: standard triple therapy, ciprofloxacin based triple therapy, quadruple and sequential therapy Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 31(4): 303-307
Adamek, R.J.; Opferkuch, W.; Wegener, M. 1995: Modified short-term triple therapy--ranitidine, clarithromycin, and metronidazole--for cure of Helicobacter pylori infection American Journal of Gastroenterology 90(1): 168-169
Kullavanijaya, P.; Gonlachanvit, S.; Mahachai, V.; Kladchareon, N. 2000: Eradication of Helicobacter pylori with lansoprazole based triple therapy in peptic ulcer disease Journal of the Medical Association of Thailand 83(3): 230-235
Flores, S.; Opazo, H.; Valderrama, D.; Aguilera, R.; Marchese, A.; Valderrama, S. 2000: Triple therapy of short-term with azithromycin, amoxycillin and omeprazole for the eradication of Helicobacter pylori Revista Medica de Chile 128(5): 509-512
Uthaisaengsook, W. 2003: Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection Journal of the Medical Association of Thailand 86(7): 599-602
Gisbert, J.P.; Boixeda, D.; Martín de Argila, C.; García Plaza, A. 1999: Antral biopsy is sufficient to confirm Helicobacter pylori eradication with the "new" one-week long triple treatments Medicina Clinica 112(10): 365-367
Brzozowski, T.; Konturek, P.C.; Kwiecien, S.; Konturek, S.J.; Pajdo, R.; Drozdowicz, D.; Ptak, A.; Pawlik, M.; Stachura, J.; Pawlik, W.W.; Hahn, E.G. 2003: Triple eradication therapy counteracts functional impairment associated with Helicobacter pylori infection in Mongolian gerbils Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 54(1): 33-51
Parzecka, M.; Szaflarska-Popławska, A.; Mierzwa, G.; Gorzkiewicz, M.; Łuczak, S.; Grzybowski, T. 2009: Genetic type of Helicobacter pylori and the efficacy of eradication therapy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 26(152): 105-109
Tursi, A.; Cammarota, G.; Montalto, M.; Papa, A.; Cuoco, L.; Veneto, G.M.; Cannizzaro, O.; Fedeli, G.; Gasbarrini, G. 1996: Evaluation of the efficacy and tolerability of four different therapeutic regimens for the Helicobacter pylori eradication Panminerva Medica 38(3): 145-149
Toyama, J.; Kato, C.; Sato, K.; Sato, S. 1999: The 13C-urea breath test efficacy in determining Helicobacter pylori eradication Nihon Rinsho. Japanese Journal of Clinical Medicine 57(1): 93-96
Koizumi, W.; Tanabe, S.; Imaizumi, H.; Hibi, K-ichi.; Kida, M.; Ohida, M.; Okayasu, I.; Saigenji, K. 2003: Effect of anti-Helicobacter pylori IgG antibody titer following eradication of Helicobacter pylori infection Hepato-Gastroenterology 50(49): 293-296